Starpharma Holdings Limited (ASX:SPL)

Starpharma Holdings Revenue

In the fiscal year ending June 30, 2026, Starpharma Holdings had annual revenue of 12.67M AUD with 116.55% growth. Starpharma Holdings had revenue of 1.51M in the half year ending June 30, 2026, a decrease of -12.59%.

• Revenue: 12.67M
• Revenue Growth: +116.55%
• P/S Ratio: 29.55
• Revenue / Employee: 253.36K
• Employees: 50
• Market Cap: 374.33M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	12.67M	6.82M	116.55%
Jun 30, 2025	5.85M	-3.91M	-40.04%
Jun 30, 2024	9.76M	5.41M	124.64%
Jun 30, 2023	4.34M	-819.00K	-15.87%
Jun 30, 2022	5.16M	1.68M	48.04%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 10, 2026

Data Sources Report a data error